Unlisted
| Company Name | (주)인트론바이오테크놀로지 |
| English Name | iNtRON Biotechnology, Inc. |
| Business Reg. No. | 2158174710 |
| CEO | 윤성준, 윤경원(각자대표) |
| Address | 경기도 성남시 중원구 사기막골로 137 중앙인더스피아 5차 701~704호 |
| Industry | 그 외 기타 분류 안된 화학제품 제조업 |
| Industry Code | 211 |
| Main Products | 단백질 신약, 박테리오파지 항생제 대체제, 분자진단키트, 유전자시약 |
| Established | 19990118 |
| Phone | 031-739-5678 |
| Website | www.intron.co.kr/ |
| Regular Employees | 73persons |
| Corp. Reg. No. | 1101111636004 |
Venture Certified
| 연구개발기업 | 1999-11-23 ~ 2001-06-30 | 1999113571-1791 | 1999-11-23 |
| 연구개발기업 | 2001-07-02 ~ 2003-07-01 | 031622032200149 | 1999-11-23 |
| 연구개발기업 | 2003-07-02 ~ 2005-07-01 | 031622021200601 | 1999-11-23 |
| 연구개발기업 | 2005-07-02 ~ 2007-07-01 | 051622021300952 | 1999-11-23 |
| 기술평가보증기업(기금) | 2007-07-02 ~ 2008-07-01 | 20070201159 | 1999-11-23 |
| 기술평가보증기업(기금) | 2008-07-02 ~ 2009-07-01 | 20080104362 | 1999-11-23 |
| 기술평가보증기업(기금) | 2009-07-02 ~ 2011-07-01 | 20090106345 | 1999-11-23 |
| 기술평가보증기업(기금) | 2011-07-02 ~ 2013-07-01 | 20110104135 | 1999-11-23 |
| 기술평가보증기업(기금) | 2013-07-02 ~ 2015-07-01 | 20130106145 | 1999-11-23 |
| 연구개발유형 | 2015-07-02 ~ 2017-07-01 | 20150106506 | 1999-11-23 |
| 연구개발유형 | 2017-07-02 ~ 2019-07-01 | 20170107868 | 1999-11-23 |
| 연구개발유형 | 2019-07-02 ~ 2021-07-01 | 20190106791 | 1999-11-23 |
| 연구개발유형 | 2021-07-02 ~ 2024-07-01 | 20210804020075 | 1999-11-23 |
| 연구개발유형 | 2024-07-02 ~ 2027-07-01 | 20240821020007 | 1999-11-23 |
Revenue CAGR -39.7%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 64B | 96B | 140B | 293B |
| Operating Profit | -52B | -33B | -15B | 101B |
| Net Profit | -26B | -97B | 57B | 97B |
| Total Assets | 864B | 986B | 1,410B | 1,534B |
| Total Liabilities | 26B | 19B | 348B | 520B |
| Total Equity | 838B | 967B | 1,062B | 1,013B |
Operating Loss: Op. profit -52B
Revenue down 33% YoY
2 Consecutive Years of Net Loss
Debt Ratio Surge (+1pp YoY)
▼ 63.6%
▼ 395.7%
▼ 2244.0%
▼ 89.2%
▼ 287.3%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 윤성준 | 사내이사 | 대표이사 경영총괄 | - |
| 김성우 | 미등기 | 재무/기획 | - |
| 윤경원 | 사내이사 | 대표이사 재무/기획 | - |
| 강상현 | 미등기 | 연구개발 | - |
| 설재구 | 사내이사 | 연구개발 | - |
| 윤종성 | 감사 | 감사 | - |
| 전수연 | 미등기 | 연구개발 | - |
| 박지성 | 미등기 | 연구행정 | - |
| 박만순 | 미등기 | 영업/ 마케팅 | - |
| 김수진 | 미등기 | 영업/ 마케팅 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| Regular Employees | 73persons |
| CEO | 윤성준, 윤경원(각자대표) |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 성남시",
"ceo_name": "윤성준, 윤경원",
"certificate": [
{
"cert_number": "1999113571-1791",
"changes": "",
"disclosure_date": "1999-11-23",
"first_cert_date": "1999-11-23",
"no": "1",
"type": "연구개발기업",
"valid_period": "1999-11-23 ~ 2001-06-30"
},
{
"cert_number": "031622032200149",
"changes": "",
"disclosure_date": "2001-07-02",
"first_cert_date": "1999-11-23",
"no": "2",
"type": "연구개발기업",
"valid_period": "2001-07-02 ~ 2003-07-01"
},
{
"cert_number": "031622021200601",
"changes": "",
"disclosure_date": "2003-07-02",
"first_cert_date": "1999-11-23",
"no": "3",
"type": "연구개발기업",
"valid_period": "2003-07-02 ~ 2005-07-01"
},
{
"cert_number": "051622021300952",
"changes": "",
"disclosure_date": "2005-07-02",
"first_cert_date": "1999-11-23",
"no": "4",
"type": "연구개발기업",
"valid_period": "2005-07-02 ~ 2007-07-01"
},
{
"cert_number": "20070201159",
"changes": "",
"disclosure_date": "2007-06-18",
"first_cert_date": "1999-11-23",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2007-07-02 ~ 2008-07-01"
},
{
"cert_number": "20080104362",
"changes": "",
"disclosure_date": "2008-06-23",
"first_cert_date": "1999-11-23",
"no": "6",
"type": "기술평가보증기업(기금)",
"valid_period": "2008-07-02 ~ 2009-07-01"
},
{
"cert_number": "20090106345",
"changes": "",
"disclosure_date": "2009-06-30",
"first_cert_date": "1999-11-23",
"no": "7",
"type": "기술평가보증기업(기금)",
"valid_period": "2009-07-02 ~ 2011-07-01"
},
{
"cert_number": "20110104135",
"changes": "",
"disclosure_date": "2011-06-30",
"first_cert_date": "1999-11-23",
"no": "8",
"type": "기술평가보증기업(기금)",
"valid_period": "2011-07-02 ~ 2013-07-01"
},
{
"cert_number": "20130106145",
"changes": "",
"disclosure_date": "2013-06-24",
"first_cert_date": "1999-11-23",
"no": "9",
"type": "기술평가보증기업(기금)",
"valid_period": "2013-07-02 ~ 2015-07-01"
},
{
"cert_number": "20150106506",
"changes": "",
"disclosure_date": "2015-06-25",
"first_cert_date": "1999-11-23",
"no": "10",
"type": "연구개발유형",
"valid_period": "2015-07-02 ~ 2017-07-01"
},
{
"cert_number": "20170107868",
"changes": "",
"disclosure_date": "2017-07-03",
"first_cert_date": "1999-11-23",
"no": "11",
"type": "연구개발유형",
"valid_period": "2017-07-02 ~ 2019-07-01"
},
{
"cert_number": "20190106791",
"changes": "",
"disclosure_date": "2019-06-19",
"first_cert_date": "1999-11-23",
"no": "12",
"type": "연구개발유형",
"valid_period": "2019-07-02 ~ 2021-07-01"
},
{
"cert_number": "20210804020075",
"changes": "",
"disclosure_date": "2021-08-04",
"first_cert_date": "1999-11-23",
"no": "13",
"type": "연구개발유형",
"valid_period": "2021-07-02 ~ 2024-07-01"
},
{
"cert_number": "20240821020007",
"changes": "대표자",
"disclosure_date": "2024-08-21",
"first_cert_date": "1999-11-23",
"no": "14",
"type": "연구개발유형",
"valid_period": "2024-07-02 ~ 2027-07-01"
}
],
"company_name": "㈜인트론바이오테크놀로지",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 17075381000,
"cost_of_sales": 4348762000,
"current_assets": 112749455000,
"current_liabilities": 32215384000,
"gross_profit": 9658216000,
"net_income": 8291665000,
"net_income_bs": 5721077000,
"non_current_assets": 28854945000,
"non_current_liabilities": 2523460000,
"non_operating_expenses": 8463237000,
"non_operating_income": 18087911000,
"operating_profit": -1333009000,
"revenue": 14006978000,
"sga_expenses": 10991224000,
"total_assets": 141604400000,
"total_equity": 106865556000,
"total_liabilities": 34738843000
},
"2023": {
"capital_stock": 17075381000,
"cost_of_sales": 3741960000,
"current_assets": 59820995000,
"current_liabilities": 785510000,
"gross_profit": 5843484000,
"net_income": -11841412000,
"net_income_bs": -10652215000,
"non_current_assets": 38392097000,
"non_current_liabilities": 1010404000,
"non_operating_expenses": 13926300000,
"non_operating_income": 5316341000,
"operating_profit": -3231453000,
"revenue": 9585444000,
"sga_expenses": 9074938000,
"total_assets": 98213092000,
"total_equity": 96417178000,
"total_liabilities": 1795913000
}
},
"industry": "그 외 기타 분류 안된 화학제품 제조업",
"investment": [],
"main_products": "단백질 신약, 박테리오파지 항생제 대체제, 분자진단키트, 유전자시약",
"phone": "031-739-****",
"years": [
2023,
2022
]
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |